Subgroup Analysis of the Interim Results of a Prospective, Randomized, Double Blinded, Placebo Controlled, Phase IIb Trial of the Autologous TLPLDC Vaccine in Stage III/ IV ( Resected) Melanoma Patients to Prevent Recurrence-MedSci.cn

Subgroup Analysis of the Interim Results of a Prospective, Randomized, Double Blinded, Placebo Controlled, Phase IIb Trial of the Autologous TLPLDC Vaccine in Stage III/ IV ( Resected) Melanoma Patients to Prevent Recurrence

Myers, JW; Clifton, GT; Vreeland, TJ; Brown, TA; Peace, K; Greene, JM; Jackson, DO; Hale, DF; Peoples, GE; Faries, MB

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018; 227 (4): S249

科室
- - 订阅+
  - 更多科室
工具
服务